Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01975831
What this trial is testing

Evaluate MEDI4736 in Combination With Tremelimumab

Who this might be right for
Breast CancerOvarian CancerColorectal Cancer+2 more
Ludwig Institute for Cancer Research 104
Testing effectiveness (Phase 2)UnknownNCT03262545
What this trial is testing

Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian Cancer

Who this might be right for
Angiogenesis Inhibitors，Ovarian Neoplasms
Sichuan Cancer Hospital and Research Institute 60
Not applicableStudy completedNCT00488202
What this trial is testing

Advanced Ovarian Cancer and Sexuality Phase 1

Who this might be right for
Ovarian CancerSexual Function
University of British Columbia 26
Post-approval studies (Phase 4)UnknownNCT01631253
What this trial is testing

The Impact on Ovarian Reserve After Single-port, Two-port, or Four-port Access Laparoscopic Ovarian Cyst Enucleation

Who this might be right for
Ovarian Cyst
CHA University 90
Testing effectiveness (Phase 2)Ended earlyNCT04377087
What this trial is testing

Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Sarah E Taylor 3
Early research (Phase 1)Ended earlyNCT06466187
What this trial is testing

SGN-MesoC2 in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Adenocarcinoma+4 more
Seagen, a wholly owned subsidiary of Pfizer 19
Testing effectiveness (Phase 2)UnknownNCT04072263
What this trial is testing

Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer Recurrent
Leiden University Medical Center 12
Not applicableEnded earlyNCT01744821
What this trial is testing

Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Northwestern University 7
Testing effectiveness (Phase 2)Study completedNCT00194714
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab

Who this might be right for
HER2/Neu PositiveHLA-A2 Positive Cells PresentStage IV Breast Cancer+1 more
University of Washington 22
Not applicableStudy completedNCT06201221
What this trial is testing

Single-port Laparoscopy in Children and Adolescents

Who this might be right for
Benign Ovarian Tumors
Fujian Maternity and Child Health Hospital 300
Testing effectiveness (Phase 2)UnknownNCT06541314
What this trial is testing

Fluzoparib Neoadjuvant Therapy for Ovarian Cancer

Who this might be right for
Ovarian Cancer
Qilu Hospital of Shandong University 48
Not applicableActive Not RecruitingNCT00579163
What this trial is testing

Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsColonic Neoplasms+4 more
Memorial Sloan Kettering Cancer Center 992
Not applicableLooking for participantsNCT06545721
What this trial is testing

Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Peking Union Medical College Hospital 425
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Testing effectiveness (Phase 2)Study completedNCT00002671
What this trial is testing

Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT01277744
What this trial is testing

Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor

Who this might be right for
Advanced CancersSarcoma
M.D. Anderson Cancer Center 22
Not applicableStudy completedNCT06145295
What this trial is testing

The Effectiveness of an Online Support Group in Enhancing Recovery Identity and Health-Related Quality of Life

Who this might be right for
Ovarian Cancer
Shanghai Jiao Tong University School of Medicine 68
Testing effectiveness (Phase 2)UnknownNCT01100372
What this trial is testing

Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Medical University Innsbruck 154
Early research (Phase 1)Study completedNCT00315861
What this trial is testing

Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer+1 more
SCRI Development Innovations, LLC 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04561362
What this trial is testing

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Who this might be right for
Urinary Bladder NeoplasmTriple Negative Breast NeoplasmsHormone Receptor Positive, HER2-negative Neoplasms+5 more
BicycleTx Limited 329
Next Page